Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAGE Sage Therapeutics

休市中 11-22 16:00:00 EST

5.17

+0.32

+6.60%

盘后5.10

-0.07-1.35%

19:58 EST

最高5.21	最低4.85	成交量87.10万
今开4.85	昨收4.85	日振幅7.42%
总市值3.16亿	流通市值2.50亿	总股本6,117万
成交额443.63万	换手率1.80%	流通股本4,835万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAGE","market":"US","secType":"STK","nameCN":"Sage Therapeutics","latestPrice":5.17,"timestamp":1732309200000,"preClose":4.85,"halted":0,"volume":871036,"hourTrading":{"tag":"盘后","latestPrice":5.1,"preClose":5.17,"latestTime":"19:58 EST","volume":11445,"amount":59157.12,"timestamp":1732323496653},"delay":0,"floatShares":48350863,"shares":61173263,"eps":-5.585057,"marketStatus":"休市中","marketStatusCode":7,"change":0.32,"latestTime":"11-22 16:00:00 EST","open":4.85,"high":5.21,"low":4.85,"amount":4436325.4524492,"amplitude":0.074227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.585057,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1405656000000,"adjPreClose":4.85,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.85,"preClose":4.85,"latestTime":"09:29 EST","volume":948,"amount":4597.809859200001,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":5.1,"preClose":5.17,"latestTime":"19:58 EST","volume":11445,"amount":59157.12,"timestamp":1732323496653},"volumeRatio":0.7204871781154484,"impliedVol":1.3942,"impliedVolPercentile":0.9722},"requestUrl":"/m/hq/s/SAGE/tweets","defaultTab":"tweets","newsList":[{"id":"2485262504","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485262504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485262504?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:56","pubTimestamp":1732287368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时56分，Sage Therapeutics, Inc.股票出现异动，股价急速上涨5.36%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1269.37%、97.45%、75.27%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为48.21%、42.08%、33.00%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222560898e442ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222560898e442ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2485497763","title":"Sage Therapeutics, Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497763?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199487,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分，Sage Therapeutics, Inc.股票出现异动，股价大幅拉升5.70%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为211.05%、55.79%、41.53%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.、Assembly Biosciences, Inc.，振幅分别为14.55%、14.30%、12.18%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223128971a7df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223128971a7df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2485550431","title":"美国研究综述-微策略、雪花、目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2485550431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485550431?lang=zh_cn&edition=full","pubTime":"2024-11-21 14:34","pubTimestamp":1732170896,"startTime":"0","endTime":"0","summary":"    路透11月21日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Microstrategy、Snowflake 和 Target。要闻              * Dycom Industries Inc   ：D.A. Davidson将目标价从210美元上调至220美元             * Microstrategy Inc   ：BTIG将目标价从290美元上调至570美元             * Snowflake Inc   ：Piper Sandler 将目标价从 165 美元上调至 185 美元             * Target Corp   ：杰富瑞将目标价从 195 美元下调至 165 美元             * Williams-Sonoma Inc   ：杰富瑞将目标价从 156 美元上调至 194 美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","JACK","LU1244550221.USD","IE0004445239.USD","LU0963586101.USD","BK4109","BK4532","MSTR","LU2506952097.USD","BK4592","BK4533","FMNB","LU2237443549.SGD","IE00B19Z9Z06.USD","FWONK","LU2506952170.USD","TPIC","LU1989772840.SGD","BK4209","LU0211327993.USD","TJX","PYXS","SNOW","BK4111","LU0889565833.HKD","BK4023","BERY","BRBR","LU2237443978.SGD","LU2237443382.USD","LU1803068979.SGD","BK4561","BK4600","BK4116","LU1951198990.SGD","SAGE","BK4535","BK4585","BK4108","BK4596","TGT","BK4183","IE00B1BXHZ80.USD","NWSA","IE00B19Z9P08.USD","DNMR","DY","BK4094","BK4595"],"gpt_icon":1},{"id":"2484001146","title":"BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2484001146","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484001146?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:57","pubTimestamp":1732118258,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.28%，报43,145.73点。标普500指数.SPX下跌0.78%，报5870.84点；纳斯达克综合指数.IXIC下跌1.16%，报18769.66点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Keysight Technologies Inc KEYS.N，上涨 5.9. nL4N3MR0SH  ** 金山云控股有限公司KC.O:BUZZ - 因第三季度亏损小于预期而上涨 nL8N3MR11B  ** Silvercorp Metals Inc SVM.N:BUZZ - 在公布可转换债务交易后下跌 nL6N3MR0HA  ** Tapestry Inc TPR.N： ** Capri Holdings Ltd CPRI.N:BUZZ - 巴克莱恢复对Tapestry和Capri的覆盖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPAI","BGC","LU0289961442.SGD","BK4539","CTVA","LU0788108826.HKD","LU0950375773.USD","BK4195","POWL","DTM","BK4507","CMCSA","OMCL","BK4516","GDRX","LU0980610538.SGD","F","LU1430597077.USD","TJX","WIX","LU0094547139.USD","LU0310800965.SGD","LMND","SM","MNPR","WSM","IE00B1BXHZ80.USD","INSP","BK4554","VKTX","DAL","BK4555","CPRI","LU0075056555.USD","MBIN","QDEL","TGT","FLEX","SAGE","CMI","LU1280957306.USD","NEM","TPR","LU1267930490.SGD"],"gpt_icon":1},{"id":"2484110660","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110660?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:34","pubTimestamp":1732113260,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时34分，Sage Therapeutics, Inc.股票出现波动，股价快速下跌5.30%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Forte Biosciences, Inc.涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为501.30%、184.85%、106.42%，振幅较大的相关个股有Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为35.85%、30.55%、23.42%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223420971a7ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223420971a7ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2484112793","title":"BUZZ--美国股票走势-康卡斯特、Wix.com、Flex","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484112793?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113071,"startTime":"0","endTime":"0","summary":"** Wix.com Ltd   : BUZZ - 因上调财年营收和预订预期而跳涨   ** GoodRx Holdings Inc   : BUZZ - Leerink 表示，该公司是价值被低估最严重的股票之一，    。** 达美航空  : BUZZ - 预测 2025 年收入将实现中等个位数增长，随后上涨。** 金山云控股有限公司  : BUZZ - 因第三季度亏损小于预期而上涨   ** Silvercorp Metals Inc   : BUZZ - 在公布可转换债务交易后下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0630314457.HKD","LU1150488218.USD","BK4567","DAL","LU0289961442.SGD","WIX","MBIN","NEM","LU2098885051.SGD","CMCSA","COIN","MNPR","SM","VKTX","LU0612318385.USD","LU0456854461.SGD","BK4195","BK4114","BK4198","LU0320765489.SGD","BK4554","BK4596","MARA","SAGE","RIOT","BK4008","BK4100","LU1280957306.USD","CTVA","BGC","BK4551","LU0823411888.USD","LU1861559042.SGD","FLEX","BK4516","TGT","SPAI","LU0788108826.HKD","LU0154245756.USD","QDEL","BK4112","LU0057025933.USD","LU1223083913.SGD","CMI","LU0648001328.SGD","GDRX","LU0124676726.USD"],"gpt_icon":1},{"id":"2484011698","title":"BUZZ-Sage Therapeutics 停止开发罕见病药物后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2484011698","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484011698?lang=zh_cn&edition=full","pubTime":"2024-11-20 21:27","pubTimestamp":1732109220,"startTime":"0","endTime":"0","summary":"11月20日 - ** 药物开发商 Sage Therapeutics 的 SAGE.O 股价盘前下跌 4.3% 至 4.70 美元** 该公司表示，由于在一项中期试验中没有达到主要目标 ，它将停止进一步开发其试验性药物dalzanemdor。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SAGE"],"gpt_icon":0},{"id":"2484940561","title":"更新版 1-Sage Therapeutics因中期研究失败而放弃罕见病药物的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2484940561","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484940561?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:54","pubTimestamp":1732103650,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (在第2段中增加了股票，并在全文中提供了详细信息)    路透11月20日 - 药物开发商Sage Therapeutics   周三表示 ，其治疗亨廷顿氏病患者认知障碍的实验性药物在一项中期研究失败后将停止开发。与安慰剂相比，这种名为dalzanemdor的药物在84天后没有明显改善患者的认知功能，未能达到研究的主要目标。萨奇说，该药物在研究的次要目标中也没有达到 \"统计学意义\"。 亨廷顿氏病是一种遗传性疾病，会导致大脑部分神经细胞逐渐坏死。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2484917381","title":"Sage Therapeutics的罕见病药物未能通过中期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2484917381","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484917381?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:36","pubTimestamp":1732102572,"startTime":"0","endTime":"0","summary":"Sage Therapeutics的罕见病药物未能通过中期研究路透11月20日 - Sage Therapeutics SAGE.O周三表示，在一项针对罕见遗传性神经疾病亨廷顿氏病患者的中期研究中，其实验性药物未能达到主要目标。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE","BK4139"],"gpt_icon":0},{"id":"2484671616","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.10%报4.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671616?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940393,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分，Sage Therapeutics, Inc.股票出现波动，股价大幅下挫5.10%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为517.58%、212.65%、190.21%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为57.71%、35.15%、34.31%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822331398e433d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822331398e433d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2483820593","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.06%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483820593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483820593?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:34","pubTimestamp":1731605670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时34分，Sage Therapeutics, Inc.股票出现波动，股价快速下跌5.06%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、奥麦罗制药涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为3671.25%、3218.98%、365.57%，振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为249.67%、112.92%、106.82%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013430abc1c36d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013430abc1c36d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2482736280","title":"Sage Therapeutics, Inc.盘中异动 早盘急速上涨5.07%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482736280?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:19","pubTimestamp":1731338379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时19分，Sage Therapeutics, Inc.股票出现波动，股价快速拉升5.07%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为464.83%、397.77%、126.67%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bionomics Ltd Ads Each Rep 180 Ord Shs，振幅分别为123.43%、40.91%、30.43%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231939971a5beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231939971a5beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2481380581","title":"Sage Therapeutics, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481380581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481380581?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:25","pubTimestamp":1730996745,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时25分，Sage Therapeutics, Inc.股票出现异动，股价大幅拉升5.21%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celularity Inc.、Ensysce Biosciences, Inc.、Coherus Biosciences, Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为832.79%、297.55%、101.80%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108002545abaab175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108002545abaab175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2481600086","title":"Sage Therapeutics, Inc.盘中异动 早盘急速拉升5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481600086?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903446,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，Sage Therapeutics, Inc.股票出现波动，股价大幅拉升5.89%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Macrogenics, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1008.30%、97.66%、48.12%，振幅较大的相关个股有阿卡迪亚、Meiragtx Holdings Plc、Xencor, Inc.，振幅分别为105.47%、105.31%、105.02%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223049a21d2990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223049a21d2990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2480755148","title":"Sage Therapeutics, Inc.2024财年第三财季实现净利润-93.55百万美元，同比增加53.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480755148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480755148?lang=zh_cn&edition=full","pubTime":"2024-11-03 00:01","pubTimestamp":1730563284,"startTime":"0","endTime":"0","summary":"11月3日，Sage Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-93.55百万美元，同比增加53.69%；其中营业收入为11.87百万美元，同比增加336.40%，每股基本收益为-1.53美元。机构评级：截至2024年11月3日，当前有18家机构对Sage Therapeutics, Inc.目标价做出预测，其中目标均价为10.17美元，其中最低目标价为4.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000223a20f7bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000223a20f7bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ"],"gpt_icon":0},{"id":"2479033778","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033778?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:08","pubTimestamp":1730383733,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时08分，Sage Therapeutics, Inc.股票出现异动，股价急速下挫5.26%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.81%。其相关个股中，Aerovate Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为221.53%、221.48%、155.40%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为45.05%、39.30%、32.39%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220854ab8bbbd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220854ab8bbbd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"1157270159","title":"异动解读 | 2024年第三季度业绩亏损超预期 SAGE Therapeutics股价盘中大跌9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157270159","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157270159?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:37","pubTimestamp":1730295449,"startTime":"0","endTime":"0","summary":"SAGE Therapeutics公司今日盘中股价大跌9.32%,报收于48.97美元,引发了市场的广泛关注。这一大幅下跌或与公司2024年第三季度业绩表现不佳密切相关。SAGE Therapeutics在当日晚间公布的2024年第三季度财报显示,公司调整后每股亏损为1.53美元,而去年同期则为每股收益3.37美元。公司该季度净亏损高达9355万美元,大幅高于市场预期。SAGE Therapeutics连续多个季度亏损数据超预期,加之今年以来其股价已下跌超60%的背景,似乎引发了市场对该公司前景增长乏力的担忧。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAGE"],"gpt_icon":0},{"id":"2479785393","title":"Sage Therapeutics, Inc.盘中异动 股价大跌9.32%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479785393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479785393?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:30","pubTimestamp":1730295025,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时30分，Sage Therapeutics, Inc.股票出现异动，股价大幅下跌9.32%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Biovie Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1587.49%、95.91%、13.86%，振幅较大的相关个股有Kairos Pharma, Ltd.、Coherus Biosciences, Inc.、Ensysce Biosciences, Inc.，振幅分别为2.99%、2.15%、1.47%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021302598e3f64a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021302598e3f64a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"1181045992","title":"异动解读 | SAGE Therapeutics公布2024年第三季度业绩亏损扩大,盘后股价大跌15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181045992","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181045992?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:56","pubTimestamp":1730256991,"startTime":"0","endTime":"0","summary":"SAGE Therapeutics公司2024年第三季度财报公布后股价盘后大跌15.09%,引发市场广泛关注。财报数据显示,SAGE Therapeutics在2024年第三季度继续亏损,亏损金额较去年同期大幅扩大。具体来看,SAGE Therapeutics报告2024年第三季度调整后每股亏损1.53美元,而去年同期则为每股收益3.37美元。公司当季度亏损高达9355万美元,亏损幅度大大超出市场预期。尽管SAGE Therapeutics第三季度营收同比大增337.1%至1187万美元,但显然营收增长未能抵消成本费用的大幅上升,导致公司季度亏损明显扩大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAGE"],"gpt_icon":0},{"id":"2479021349","title":"SAGE Therapeutics Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479021349","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479021349?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:52","pubTimestamp":1730256758,"startTime":"0","endTime":"0","summary":"   * SAGE Therapeutics Inc   报告，截至1月1日的季度调整后每股亏损1.53美元，高于去年同期的每股收益3.37美元。华尔街预期为每股亏损 1.74 美元至 1.20 美元。* 营收同比增长 337.1%，达到 1187 万美元；分析师预期为 1080 万美元。* SAGE Therapeutics 公司公布的本季度每股收益为亏损 1.53 美元。* SAGE Therapeutics Inc 本季度股价上涨了 18.3%，今年迄今为止亏损了 60.6%。华尔街对 SAGE Therapeutics Inc 的 12 个月目标价中位数为 10.00  本摘要由 LSEG 数据于 10 月 30 日 02:51 a.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagerx.com","stockEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":-0.3242},{"period":"3month","weight":-0.3853},{"period":"6month","weight":-0.5611},{"period":"1year","weight":-0.7339},{"period":"ytd","weight":-0.7614}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司，其使命是开拓解决方案，提供改变生命的大脑健康药物，让每个人都能茁壮成长。除了产后抑郁症商业产品外，该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司，该公司专注于大脑健康，目前他们的目标是两个关键的中枢神经系统受体系统，GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质，通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038293},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021443},{"month":3,"riseRate":0.4,"avgChangeRate":-0.042022},{"month":4,"riseRate":0.6,"avgChangeRate":0.045083},{"month":5,"riseRate":0.4,"avgChangeRate":-0.009805},{"month":6,"riseRate":0.5,"avgChangeRate":0.012627},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009867},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.042534},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.036732},{"month":10,"riseRate":0.363636,"avgChangeRate":0.008484},{"month":11,"riseRate":0.636364,"avgChangeRate":0.052008},{"month":12,"riseRate":0.6,"avgChangeRate":0.05379}],"exchange":"NASDAQ","name":"Sage Therapeutics","nameEN":"Sage Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sage Therapeutics,SAGE,Sage Therapeutics股票,Sage Therapeutics股票老虎,Sage Therapeutics股票老虎国际,Sage Therapeutics行情,Sage Therapeutics股票行情,Sage Therapeutics股价,Sage Therapeutics股市,Sage Therapeutics股票价格,Sage Therapeutics股票交易,Sage Therapeutics股票购买,Sage Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}